Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA May Need To Reduce Timeframe For Inspecting Flu Vaccine Facilities, Rep. Davis Says

This article was originally published in The Pink Sheet Daily

Executive Summary

House Government Reform Committee Chairman Tom Davis (R-Va.) indicated interest in revising FDA's procedures regarding inspection of flu vaccine manufacturing facilities in light of the current supply shortage

You may also be interested in...



Chiron To Meet With U.K. Regulatory Authorities On Fluvirin Suspension

The company does not anticipate the three-month manufacturing suspension will be lifted following the Oct. 6 meeting. Chiron's projected 48 mil. doses of flu vaccine were expected to account for nearly 50% of the U.S. supply.

Rep. Waxman To FDA: Rely On Inspectors, Not Industry, For Compliance

FDA should rely more on the recommendations of its inspectors and less on regulated industry to ensure compliance, Rep. Henry Waxman (D-Calif.) said

Rep. Waxman To FDA: Rely On Inspectors, Not Industry, For Compliance

FDA should rely more on the recommendations of its inspectors and less on regulated industry to ensure compliance, Rep. Henry Waxman (D-Calif.) said

Related Content

Topics

UsernamePublicRestriction

Register

PS142970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel